Redcare Pharmacy N.V. / NL0012044747
26.09.2025 - 19:03:13Change in Redcare Pharmacy’s Managing Board: CFO Jasper Eenhorst to step down.
| EQS-Ad-hoc: Redcare Pharmacy N.V. / Key word(s): Personnel 26-Sep-2025 / 19:03 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of this announcement. Sevenum, the Netherlands, 26 September 2025. Jasper Eenhorst will be leaving Redcare Pharmacy to take on new career opportunities. He is stepping down from the Managing Board today but will remain with the company until the end of this year to support a smooth transition to his successor. The Supervisory Board has already initiated the search for a new CFO and expects the search to be concluded soon. Until a successor has been appointed, his responsibilities will be assumed on an interim basis by Olaf Heinrich, CEO of Redcare Pharmacy. Contact: rikutis consulting Thomas Schnorrenberg Cel: +49 151 46 53 13 17 E-Mail: presse@shop-apotheke.com End of Inside Information Information and Explanation of the Issuer to this announcement: The Supervisory Board thanks Jasper Eenhorst for his exceptional commitment and valuable contribution to the company’s successful development and growth. ___ Investor Relations Contact: Monica Ambrosi (Associate Director, Investor Relations) investors@redcare-pharmacy.com Press Contact: Sven Schirmer (Director, Corporate Communications) press@redcare-pharmacy.com About Redcare Pharmacy. Originally founded in 2001, Redcare Pharmacy N.V. (formerly known as Shop Apotheke Europe N.V.) today is the leading e-pharmacy in Europe, currently active in seven countries: Germany, Austria, France, Belgium, Italy, the Netherlands and Switzerland. Headquartered in Sevenum, close to the Dutch city of Venlo and in the heart of Europe, the company has locations in Cologne, Berlin, Munich, Tongeren, Warsaw, Milan, Lille and Eindhoven. As the one-stop pharmacy of the future, Redcare Pharmacy offers over 13 million active customers a wide range of more than 250,000 products at attractive and fair prices. Besides OTC, nutritional supplements, beauty and personal care products as well as an extensive assortment of health-related products in all markets, the company also provides prescription drugs for customers in Germany, Switzerland and the Netherlands. Pharmaceutical safety is of top priority. Being a pharmacy at its core, Redcare stands for comprehensive pharmaceutical consultation service. Since care is at the heart of everything Redcare does, the company provides services for all stages of life and health. This ranges from its marketplaces to unique delivery options and medication management. Redcare Pharmacy N.V. has been listed on the Regulated Market of the Frankfurt Stock Exchange (Prime Standard) since 2016. As of 19 June 2023, the company is a member of the MDAX selection index. 26-Sep-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com |
| Language: | English |
| Company: | Redcare Pharmacy N.V. |
| Erik de Rodeweg 11-13 | |
| 5975 WD Sevenum | |
| Netherlands | |
| Phone: | 0800 - 200 800 300 |
| Fax: | 0800 - 90 70 90 20 |
| E-mail: | investors@redcare-pharmacy.com |
| Internet: | www.redcare-pharmacy.com |
| ISIN: | NL0012044747, DE000A19Y072 |
| WKN: | A2AR94, A19Y072 |
| Indices: | MDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 2204650 |
| End of Announcement | EQS News Service |
| |
2204650 26-Sep-2025 CET/CEST
